The first Ukrainian licence for the importation CBD extracts and concentrates has been granted to a Canadian company.

C21 Investments has been issued a licence that will enable it to import finished products as well as raw extracts and concentrates. It will also be able to process, distribute and re-export CBD products made from the raw ingredients brought into Ukraine.

The licence issued by the State Service of Ukraine on Medicines and Drugs Control also marks C21 Investments’ first foray into the European market.

The company plans to expand its foothold rapidly in terms of both what it is permitted to do in Ukraine and the wider European market. Ukraine is not a member of the EU but maintains close links through the Ukraine–European Union Association Agreement and a series of free trade agreements.

Read full article
I'm already a subscriber

Freddie Dawson

Managing editor, news
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization